Repare Therapeutics Inc. SEC Filings

Filed On	Filing
14 May 2026	SCHEDULE 13G/A
19 Feb 2026	15-12G
30 Jan 2026	EFFECT
30 Jan 2026	Form 4: Bvf Partners L P/IL, 10% owner and 9 others Disposed of 10,166,943 shares (Tender Offer)
30 Jan 2026	SCHEDULE 13D/A
28 Jan 2026	Form 4: Civik Thomas, Director Returned 7,500 shares to the issuer
28 Jan 2026	Form 4: Forte Steve, EVP, CHIEF FINANCIAL OFFICER Returned 56,786 shares to the issuer · Disposed of 1,110,800 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Alves Sandra Isabelle Barros, SVP, Finance and CAO Returned 31,622 shares to the issuer · Disposed of 50,500 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Schafer Carol, Director Returned 8,000 shares to the issuer · Disposed of 37,941 Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Rhoads Ann D, Director Returned 4,000 shares to the issuer
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	S-8 POS
28 Jan 2026	POS AM
28 Jan 2026	25-NSE

Comments